Berry  Anderson  to  Psychiatric Status Rating Scales
                            
                            
                                This is a "connection" page, showing publications  Berry  Anderson  has written about  Psychiatric Status Rating Scales.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.143
         
        
        
     
 
    
        
        - 
            Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). Brain Stimul. 2009 Apr; 2(2):88-92.
            
            
                Score: 0.066
             
- 
            Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety. 2011 Nov; 28(11):973-80.
            
            
                Score: 0.019
             
- 
            Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry. 2010 Jan 15; 67(2):101-9.
            
            
                Score: 0.017
             
- 
            A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
            
            
                Score: 0.015
             
- 
            A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophr Res. 2007 Jul; 93(1-3):42-50.
            
            
                Score: 0.014
             
- 
            Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003 Feb; 5(1):40-7.
            
            
                Score: 0.011